摘要
目的:了解本地区女性感染支原体对抗生素的耐药情况,为临床合理用药提供依据。方法:回顾性分析165例门诊女性用法国梅里埃支原体IST2试剂盒培养支原体阳性患者的药敏试验结果。结果:165例女性泌尿道生殖感染中,解脲脲原体(Uu)、人型支原体(Mh)及Uu和Mh混合感染分别占62.4%、1.8%、35.8%。支原体对四环素类和原始霉素敏感性最好,对喹诺酮类抗生素耐药率最高。结论:支原体高耐药率提示临床在治疗女性支原体感染时应加强支原体药敏检测,根据药敏结果合理用药。推荐使用四环素类药物。
Objective: To investigate the prevalence and drug resistance of mycoplasma i.n female genitalia in local area and to provide the basic date for rational therapy.Methods: Analysis the 165 positive specimens were tests by the Bio Mycoplasma IST2 kit.Results: A total of 165 patients with the positive rate of ureaplasma urealyticum(Uu) was 62.4%, Mycoplasma hominis(Mh) was 1.8%, and mixed infection was 35.8%.The drug susceptibility test showed that mycoplasma were sensitive to the tetracycline antibiotics and pristinamycin, and high resistance to the quinolones. Conclusion: The high drugresisitance rates ofmycoplasma, it prompted antimicrobial susceptibility test should be enhanced before therapy, and according to the test result for rational therapy.Recommend tetracycline antibiotics.
出处
《中外医学研究》
2013年第5期3-4,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
解脲脲原体
人型支原体
药敏试验
Ureaplasma urealyticum
Mycoplasma hominis
Antimicrobial susceptibility test